Full-Time
Confirmed live in the last 24 hours
Tech-enabled support for cancer patients
$39.90Hourly
Senior
Remote in USA
Candidates must be based in Alaska, New York, Illinois, Michigan, and/or California.
You match the following Thyme Care's candidate preferences
Employers are more likely to interview you if you match these preferences:
Thyme Care provides support and guidance specifically for cancer patients, aiming to ensure they receive high-quality care throughout their treatment journey. The company integrates with existing clinical teams to offer continuous support, utilizing technology and oncology expertise to enhance patient care. Their services include personalized guidance for patients and acting as an extension of healthcare providers' clinical teams, aligning incentives across the healthcare system. What sets Thyme Care apart from competitors is its focus on reducing the total cost of care through targeted interventions, which have been shown to lower inpatient spending and visits. The goal of Thyme Care is to deliver high-quality cancer care while also making it more affordable for patients and healthcare providers.
Company Size
201-500
Company Stage
Series C
Total Funding
$131.3M
Headquarters
Nashville, Tennessee
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Remote Work Options
Company Equity
Oak Street Health, EmblemHealth, Vytalize Health, and several large national health plans recognize Thyme Care's patient-centric navigation and deep provider relationships as a leading value-based model that delivers on the promise of better care at lower costsThyme Care generates savings and improves the cancer experience, fueling its national expansion across Medicare Advantage, commercial health plans, employers, provider groups, and CMS's Enhancing Oncology ModelThyme Care Oncology Partners (TCOP) doubles the number of oncologists in its network since launching in March; more than 850 oncologists represented from every major managed service organization now part of the platformNASHVILLE, Tenn., Dec. 17, 2024 /PRNewswire/ -- Thyme Care today announced new strategic partnerships across the cancer care continuum, enabling the company to achieve 4x year-over-year growth in 2025. With this momentum, Thyme Care expects to bring comprehensive cancer care support services to over 40,000 people with cancer.The cancer care system is nearing a financial and logistical breaking point, strained by systemic inefficiencies and gaps in care that burden patients, providers, and payers alike. Patients and caregivers struggle to navigate a complex and siloed healthcare ecosystem, and often experience barriers to care once they leave the physician's office. Oncologists, regardless of whether they practice in the community or a hospital setting, are not incentivized in the current fee-for-service environment to provide value-based care. These challenges inflate costs for everyone in the care continuum, bringing the entire system closer to a breaking point
In May, Thyme Care launched a new palliative care telehealth offering, branded as Enhanced Supportive Care.
Concord Health Partners invested in Thyme Care for its ability to improve patient care and reduce costs.
What You Should Know:– Thyme Care, a leading value-based cancer care enabler raises $95M in funding capital led by Concord Health Partners, with participation from existing investors including CVS Health® Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Foresite Capital, and new investor SignalFire. The funding brings Thyme Care’s total funding to $178M.– Thyme Care is a value-based cancer care enabler focused on improving patient outcomes and reducing healthcare costs. The new funding will fuel Thyme Care’s expansion into new markets, deepen existing partnerships, and enhance its clinical value-based care model.Addressing the Cancer Care CrisisThe cancer care landscape is marked by escalating costs, fragmented care, and significant disparities in patient outcomes. Drug costs alone can account for up to 70% of total care expenses, with many life-saving therapies exceeding $200,000 annually. Patients often face overwhelming financial burdens, gaps in support, and a lack of care coordination.Thyme Care is addressing these challenges with a comprehensive approach that focuses on reducing costs, improving outcomes, and enhancing the patient experience.Thyme Care’s Impactful SolutionThyme Care’s value-based care model includes:24/7 specialized cancer care navigation: Guiding patients through complex treatment journeys.Guiding patients through complex treatment journeys. Advanced technology and data insights: Optimizing care delivery and identifying areas for improvement.Optimizing care delivery and identifying areas for improvement
Thyme Care, a Nashville, TN-based value-based cancer care enabler, raised $95M in Series C funding